Mick Jagger's having his heart valve replaced. The technology is better than ever
Rolling Stones frontman Mick Jagger is having a heart valve replaced this week, a source close to the band tells CNN. (Source: CNN.com - Health)
Source: CNN.com - Health - April 2, 2019 Category: Consumer Health News Source Type: news
Mick Jagger Facing Heart Surgery
Heart-valve replacement surgery typically comes with a recover of anywhere from a week to 4-to-6 weeks for open-heart surgery. (Source: WebMD Health)
Source: WebMD Health - April 2, 2019 Category: Consumer Health News Source Type: news
CMS touts ‘ more flexibility ’ in new TAVR coverage requirements
The Centers for Medicare and Medicaid Services have proposed new policy that could expand the use of transcatheter aortic valve replacement procedures, touting that it may provide more flexibility for starting and maintaining TAVR programs.
The original National Coverage Determination for TAVR procedures was cleared in 2012, when the technology and associated procedure was still new. The new policy from CMS looks to update requirements based on new information about the safety and viability of the procedures.
The new proposal, released yesterday, would reduce the number of cardiac surgeons required to independently examine...
Source: Mass Device - March 27, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiac Implants Cardiovascular Replacement Heart Valves Centers for Medicare and Medicaid Services (CMS) Source Type: news
Transcatheter Heart Valve Interventions: Where Are We? Transcatheter Heart Valve Interventions: Where Are We?
While percutaneous approaches have transformed management of valvular heart disease, more knowledge is needed to ensure optimal patient outcomes.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 27, 2019 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Top presentations at #AGS19 address prescription patterns, hypertension, frailty
(American Geriatrics Society) Data on the chronic use of opioids following spinal surgery, intensified treatment of high blood pressure after hospital discharge, and assessments of which frailty measures best predict poor outcomes following aortic heart valve replacement are among headline presentations at the American Geriatrics Society (AGS) 2019 Annual Scientific Meeting (#AGS19), held May 2-4 in Portland, Ore. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 27, 2019 Category: International Medicine & Public Health Source Type: news
Neovasc claims win in German TMVR patent case against Edwards unit CardiAQ Valve
Neovasc (NSDQ:NVCN) today claimed a win in its patent infringement war with Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve Technologies, saying a German appeals court dismissed a case there.
In June 2017 the District Court in Munich ruled that CardiAQ Valve contributed to the creation of Neovasc’s Tiara transcatheter mitral valve replacement, awarding”co-entitlement” rights to the patent in Europe. Both sides appealed that ruling, in the course of which CardiAQ withdrew its total ownership claim but asserted partial ownership, Vancouver-based Neovasc said today.
Munich’s Higher Regional Court dismiss...
Source: Mass Device - March 21, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Featured Legal News Replacement Heart Valves Wall Street Beat CardiAQ Valve Technologies Edwards Lifesciences neovasc Source Type: news
Echocardiography identifies patients for valve repair
Echocardiography can help determine which patients with heart failure and leaking...Read more on AuntMinnie.comRelated Reading:
Lung ultrasound beats chest x-ray for heart failure detection
Societies renew call to pull ultrasound contrast warning
ACC, ASE release echocardiography training guidance
ASE offers TEE guidelines for congenital heart disease
Heart valve-tracking algorithm boosts viability of 4D MRI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 19, 2019 Category: Radiology Source Type: news
ACC 2019 Roundup: Abiomed Impella RP post-market study shows benefit in select patient group
Abiomed (NSDQ:ABMD) today released 18-month post-approval study data from patients treated with its Impella RP, touting a benefit to survival for specifically selected “Recover Right” protocol patients.
Results from the study were presented at the American College of Cardiology’s 68th Annual Scientific Sessions in New Orleans, the Danvers, Mass.-based company said.
The review follows a release posted by the FDA last month warning of a 17.4% survival rate with the Impella RP heart pump system, approximately 55% lower than the rate noted in the premarket study of the device.
Abiomed said that it met with the F...
Source: Mass Device - March 18, 2019 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Assist Devices Cardiac Implants Cardiovascular Featured Patient Monitoring Replacement Heart Valves Abbott Abiomed Medtronic Source Type: news
Expandable Heart Valves Could Mean Fewer Surgeries
Expandable aortic valves are guided to the heart through a catheter into a blood vessel and placed inside the old valve. (Source: WebMD Health)
Source: WebMD Health - March 18, 2019 Category: Consumer Health News Source Type: news
ACC 2019: Medtronic, Edwards low-risk TAVR trial data could pave way to new indications
Results from trials of both Medtronic‘s (NYSE:MDT) and Edwards Lifesciences‘ (NYSE:EW) transcatheter aortic valve replacement systems exploring their use in low-risk patients indicated that the devices were as safe as open surgery, paving the way for possible new indications for TAVR technology.
Data from the trials were presented over the weekend at the American College of Cardiology 68th Annual Scientific Session 2019 in New Orleans and simultaneously published in the New England Journal of Medicine.
Currently, TAVR devices are only approved by the FDA for treating severe aortic valve stenosis in patients at inte...
Source: Mass Device - March 18, 2019 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Featured Replacement Heart Valves Edwards Lifesciences Medtronic Source Type: news
Health Highlights: March 18, 2019
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
Expandable Heart Valves Could Mean Fewer Surgeries
Expandable heart valves that can be placed in the heart through a minimally invasive... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 18, 2019 Category: General Medicine Source Type: news
Expandable Heart Valves Could Mean Fewer Heart Surgeries
Title: Expandable Heart Valves Could Mean Fewer Heart SurgeriesCategory: Health NewsCreated: 3/18/2019 12:00:00 AMLast Editorial Review: 3/18/2019 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - March 18, 2019 Category: Cardiology Source Type: news
Edwards, Medtronic heart valve systems prove worth in low-risk patients -studies
Non-invasive heart valve replacement systems from Medtronic Plc and rival Edwards Lifesciences Corp proved as good or better than open heart surgery in younger, more active patients for whom the surgical option was deemed low risk, according to trial results that had been scheduled to be presented on Sunday. (Source: Reuters: Health)
Source: Reuters: Health - March 16, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
Edwards, Medtronic heart valve systems prove worth in low-risk patients: studies
Non-invasive heart valve replacement systems from Medtronic Plc and rival Edwards Lifesciences Corp proved as good or better than open heart surgery in younger, more active patients for whom the surgical option was deemed low risk, according to trial results presented on Saturday. (Source: Reuters: Health)
Source: Reuters: Health - March 16, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
In study, TAVR is superior to surgery for low-risk patients with aortic valve stenosis
(Columbia University Irving Medical Center) A large clinical trial has found that a minimally invasive procedure to replace a narrowed heart valve performed better than surgery in patients who were good candidates for surgery. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 16, 2019 Category: International Medicine & Public Health Source Type: news
